Skip to main content
. 2011 Aug;49(8):2905–2910. doi: 10.1128/JCM.00753-11

Fig. 1.

Fig. 1.

MIC distribution of 175 clinical P. aeruginosa isolates for each carbapenem studied that were not susceptible to at least imipenem (MIC, >4 μg/ml), meropenem (MIC, >2 μg/ml), or doripenem (MIC, > 1 μg/ml).